FIELD: medicine, anesthesiology-resuscitation, infectology, detoxication.
SUBSTANCE: the innovation suggested interrupts infectious-toxic shock, moreover, after that it is necessary to prescribe peroral intake of Reaferon-EC-Lipint at the dosage of 10000 - 15000 U/kg. Then one should sample patient's blood to obtain leukocytes to be washed and diluted in 0.9%-NaCl solution, activated due to incubation with immunophan and intravenously injected for a patient. Then comes peroral intake of Reaferon-EC-Lipint at the dosage of 10000 - 15000 U/kg once daily for 5 d. The innovation enables to decrease the number of complications and lethality due to decreasing immunodeficiency.
EFFECT: higher efficiency of therapy.
3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PROPHYLAXIS OF POSTOPERATIVE PYOGENIC/SEPTIC ACCIDENTS IN PATIENTS SUFFERING FROM RECTAL CANCER | 2005 |
|
RU2281783C1 |
METHOD FOR TREATING ACUTE PURULENT-DESTRUCTIVE PULMONARY DISEASES | 2005 |
|
RU2290201C1 |
METHOD FOR PREVENTING PNEUMONIAS IN PATIENTS WITH ISCHEMIC INSULT | 2005 |
|
RU2297829C1 |
METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2010 |
|
RU2424821C1 |
METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
METHOD OF TREATING LIVER ABSCESS IN CHILDREN | 2010 |
|
RU2422146C1 |
METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
METHOD OF PROPHYLAXIS AND TREATMENT OF BURN PATIENTS WITH SEPSIS | 1995 |
|
RU2123341C1 |
METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON | 2013 |
|
RU2523554C1 |
METHOD FOR TREATING PYO-INFLAMMATORY DISEASES | 1999 |
|
RU2170591C1 |
Authors
Dates
2005-05-27—Published
2003-12-22—Filed